Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 119
Filter
1.
Sci Rep ; 14(1): 12408, 2024 05 30.
Article in English | MEDLINE | ID: mdl-38811751

ABSTRACT

Eutrophication is a main threat to continental aquatic ecosystems. Prevention and amelioration actions have been taken under the assumption of a stable climate, which needs reconsideration. Here, we show that reduced precipitation can bring a lake ecosystem to a more productive regime even with a decline in nutrient external load. By analyzing time series of several decades in the largest lake of the Iberian Peninsula, we found autocorrelated changes in the variance of state variables (i.e., chlorophyll and oxygen) indicative of a transient situation towards a new ecosystem regime. Indeed, exceptional planktonic diatom blooms have occurred during the last few years, and the sediment record shows a shift in phytoplankton composition and an increase in nutrient retention. Reduced precipitation almost doubled the water residence time in the lake, enhancing the relevance of internal processes. This study demonstrates that ecological quality targets for aquatic ecosystems must be tailored to the changing climatic conditions for appropriate stewardship.


Subject(s)
Ecosystem , Eutrophication , Lakes , Nutrients , Phytoplankton , Nutrients/analysis , Rain , Chlorophyll/analysis , Chlorophyll/metabolism , Climate Change , Diatoms/metabolism , Spain
2.
Animals (Basel) ; 14(6)2024 Mar 14.
Article in English | MEDLINE | ID: mdl-38539998

ABSTRACT

In recent decades, worldwide cetacean species have been protected, but they are still threatened. The bottlenose dolphin (Tursiops truncatus) is a vulnerable keystone species and a useful bioindicator of the health and balance of marine ecosystems in oceans all over the world. The genetic structure of the species is shaped by their niche specialization (along with other factors), leading to the classification of two ecotypes: coastal and pelagic. In this study, the genetic diversity, population structure, and ecotypes of bottlenose dolphins from the Canary Islands were assessed through the analysis of 49 new samples from biopsies and from stranded animals using the 636 bp portion of the mitochondrial control region and 343 individuals from databases (n = 392). The results reveal high genetic diversity in Canarian bottlenose dolphins (Hd = 0.969 and π = 0.0165) and the apparent lack of population genetic structure within this archipelago. High genetic structure (Fst, Φst) was found between the Canary Islands and coastal populations, while little to no structure was found with the pelagic populations. These results suggest that Canarian bottlenose dolphins are part of pelagic ecotype populations in the North Atlantic. The studied Special Areas of Conservation in the Canary Islands may correspond to a hotspot of genetic diversity of the species and could be a strategic area for the conservation of the oceanic ecotype of bottlenose dolphins.

3.
Arthroscopy ; 40(3): 869-875, 2024 03.
Article in English | MEDLINE | ID: mdl-37532161

ABSTRACT

PURPOSE: To determine clinical and radiographic outcomes of medial collateral ligament (MCL) pie-crusting during isolated medial meniscal root repair. METHODS: A retrospective review was conducted between August 2013 and December 2019 in patients undergoing isolated medial meniscal root repair. Outcomes, including International Knee Documentation Committee (IKDC) score, Lysholm score, re-tears, MCL laxity, and conversion to total knee arthroplasty (TKA), were compared between pie crust (PC) and non-pie crust (NPC) cohorts. Other assessments included subjective instability or stiffness, infection, and intra-operative chondromalacia. Additionally, radiographic outcomes were compared to determine progression of medial compartment arthrosis. RESULTS: Final analysis included 97 knees, 45 in the PC, and 52 in the NPC group. IKDC and Lysholm scores were similar between both groups preoperatively and 3 months postoperatively. However, at the 6,12, and 24-month follow up, the PC group had a significantly higher measured IKDC and Lysholm scores than the NPC group. PASS percentages for the IKDC score were significantly higher in the PC group at 6 months, 1 year, and 2 years (96.2%; P = .02) follow-up compared to the NPC group. MCID percentages for the IKDC score were also significantly higher at the 1- and 2-year (100%; P = .05) follow-up in the PC group compared to the NPC group. There was also a significantly higher rate of recurrent medial meniscal root tears in the NPC group (4 [8.9%]) compared to the PC group (0 [P = .03]). No MCL laxity was observed at 6 months follow-up. CONCLUSIONS: MCL pie-crusting during isolated medial meniscal root repair can be used as an alternative surgical technique, as it leads to improved clinical and patient outcomes compared to patients who do not undergo MCL pie-crusting in the short term. Additionally, those that underwent MCL pie-crusting had a lower incidence of recurrent tears, and no patients experienced MCL laxity at 6 months. LEVEL OF EVIDENCE: Level III, retrospective cohort/comparative study.


Subject(s)
Arthroplasty, Replacement, Knee , Knee Injuries , Medial Collateral Ligament, Knee , Humans , Arthroplasty, Replacement, Knee/methods , Follow-Up Studies , Retrospective Studies , Medial Collateral Ligament, Knee/surgery , Knee Joint/surgery , Knee Injuries/surgery
4.
J Invest Surg ; 35(2): 371-377, 2022 Feb.
Article in English | MEDLINE | ID: mdl-33371759

ABSTRACT

BACKGROUND: Transcatheter aortic valve replacement (TAVR) is an effective therapy in treating high-risk patients suffering from aortic stenosis. Animal models used to evaluate safety and efficacy of TAVR devices prior to clinical use lack a stenotic aortic annulus, a critical impediment to long-term TAVR device evaluation. We sought to create a reproducible model of aortic stenosis using a modified aortic annuloplasty (MAA) procedure in sheep, followed by deployment and long-term evaluation of TAVR devices using this model. METHODS: Twelve sheep underwent the MAA procedure and were recovered. Transthoracic echocardiography (TTE) was used to monitor changes in the aortic annulus in the postoperative period. At 60 days post-MAA, Test group animals were anesthetized for TAVR insertion and Control animals underwent a necropsy. Test animals were recovered following TAVR insertion and observed for a postoperative period of 140 days. RESULTS: Twelve sheep survived the annuloplasty procedure and the 60-day recovery period. Gross examination of seven Control group animals revealed the implanted annuloplasty ring segments formed hard protrusions into the aortic annulus. Five sheep in the Test group underwent successful deployment of Abbott's experimental TAVR device without evidence of migration. Examination at 140 days post-TAVR insertion showed all devices tightly anchored within the modified aortic annulus. CONCLUSIONS: The MAA procedure creates stenotic segments in the aortic annulus with adequate rigidity for anchorage and long-term evaluation of TAVR devices. This represents the first model that successfully mimics human aortic stenosis and provides a clinically relevant TAVR deployment platform for long-term evaluation in sheep.


Subject(s)
Aortic Valve Stenosis , Transcatheter Aortic Valve Replacement , Animals , Aortic Valve/diagnostic imaging , Aortic Valve/surgery , Aortic Valve Stenosis/diagnostic imaging , Aortic Valve Stenosis/surgery , Echocardiography , Humans , Sheep , Transcatheter Aortic Valve Replacement/adverse effects , Treatment Outcome
5.
Am J Hematol ; 94(3): 327-337, 2019 03.
Article in English | MEDLINE | ID: mdl-30569594

ABSTRACT

Innate immune complement activation may contribute to sickle cell disease (SCD) pathogenesis. Ischemia-reperfusion physiology is a key component of the inflammatory and vaso-occlusive milieu in SCD and is associated with complement activation. C5a is an anaphylatoxin, a potent pro-inflammatory mediator that can activate leukocytes, platelets, and endothelial cells, all of which play a role in vaso-occlusion. We hypothesize that hypoxia-reoxygenation (H/R) in SCD mice activates complement, promoting inflammation and vaso-occlusion. At baseline and after H/R, sickle Townes-SS mice had increased C3 activation fragments and C5b-9 deposition in kidneys, livers and lungs and alternative pathway Bb fragments in plasma compared to control AA-mice. Activated complement promoted vaso-occlusion (microvascular stasis) in SS-mice; infusion of zymosan-activated, but not heat-inactivated serum, induced substantial vaso-occlusion in the skin venules of SS-mice. Infusion of recombinant C5a induced stasis in SS, but not AA-mice that was blocked by anti-C5a receptor (C5aR) IgG. C5a-mediated stasis was accompanied by inflammatory responses in SS-mice including NF-κB activation and increased expression of TLR4 and adhesion molecules VCAM-1, ICAM-1, and E-selectin in the liver. Anti-C5aR IgG blocked these inflammatory responses. Also, C5a rapidly up-regulated Weibel-Palade body P-selectin and von Willebrand factor on the surface of human umbilical vein endothelial cells in vitro and on vascular endothelium in vivo. In SS-mice, a blocking antibody to P-selectin inhibited C5a-induced stasis. Similarly, an antibody to C5 that blocks murine C5 cleavage or an antibody that blocks C5aR inhibited H/R-induced stasis in SS-mice. These results suggest that inhibition of C5a may be beneficial in SCD.


Subject(s)
Anemia, Sickle Cell/immunology , Antibodies, Neutralizing/pharmacology , Cerebrovascular Disorders/immunology , Complement C3/immunology , Complement C5a/immunology , Receptor, Anaphylatoxin C5a/immunology , Anemia, Sickle Cell/drug therapy , Anemia, Sickle Cell/genetics , Anemia, Sickle Cell/pathology , Animals , Cerebrovascular Disorders/drug therapy , Cerebrovascular Disorders/genetics , Cerebrovascular Disorders/pathology , Complement C3/genetics , Complement C5a/antagonists & inhibitors , Complement C5a/genetics , Complement Membrane Attack Complex/genetics , Complement Membrane Attack Complex/immunology , Disease Models, Animal , E-Selectin/genetics , E-Selectin/immunology , Gene Expression Regulation , Humans , Immunity, Innate , Intercellular Adhesion Molecule-1/genetics , Intercellular Adhesion Molecule-1/immunology , Kidney/blood supply , Kidney/drug effects , Kidney/immunology , Kidney/pathology , Liver/blood supply , Liver/drug effects , Liver/immunology , Liver/pathology , Lung/blood supply , Lung/drug effects , Lung/immunology , Lung/pathology , Male , Mice , Mice, Transgenic , NF-kappa B/genetics , NF-kappa B/immunology , P-Selectin/antagonists & inhibitors , P-Selectin/genetics , P-Selectin/immunology , Receptor, Anaphylatoxin C5a/antagonists & inhibitors , Receptor, Anaphylatoxin C5a/genetics , Signal Transduction , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/immunology , Vascular Cell Adhesion Molecule-1/genetics , Vascular Cell Adhesion Molecule-1/immunology
6.
JAMA Ophthalmol ; 136(7): 747-752, 2018 07 01.
Article in English | MEDLINE | ID: mdl-29799944

ABSTRACT

Importance: Multi-institutional collaborative studies that include large patient populations for the management of retinoblastoma with histopathological risk factors could provide important information for patient management. Objective: To evaluate the implementation of a strategy for the management of nonmetastatic unilateral retinoblastoma in children based on standardized diagnostic and treatment criteria. Design, Setting, and Participants: This single-arm prospective study applied a strategy based on a single-center experience. The setting was a multicenter study in Latin America (Grupo de America Latina de Oncologia Pediatrica [GALOP]). Participants were children with nonmetastatic unilateral retinoblastoma (staged with the International Retinoblastoma Staging System). The study opened on July 1, 2008, and closed on December 31, 2014. Follow-up was updated until June 30, 2017. Interventions: Stage 0 patients (without enucleation) were given conservative therapy without a protocol. Stage I patients (with enucleation and no residual tumor) were divided into a high-risk group (retrolaminar invasion and/or scleral invasion) and a low-risk group (all remaining patients). High-risk children received adjuvant chemotherapy with 4 alternating cycles of regimen 1 (cyclophosphamide [65 mg/kg/d] [plus sodium-2-mercaptoethane sulfonate], idarubicin hydrochloride [10 mg/m2/d], and vincristine sulfate [0.05 mg/kg/d]) and 4 cycles of regimen 2 (carboplatin [500 mg/m2/d, days 1 and 2] and etoposide [100 mg/m2/d, days 1-3]). Low-risk children did not receive adjuvant therapy. Children with buphthalmia received neoadjuvant and adjuvant chemotherapy for a total of 8 cycles. Main Outcomes and Measures: Probability of event-free survival (extraocular relapse and death from any cause were considered events). Results: Among 187 children registered in the study, 175 were evaluable (92 [52.5%] female; median age, 22 months; age range, 3-100 months). Forty-two were stage 0 children, 84 were stage I low-risk children, and 42 were stage I high-risk children; there were 7 children in the buphthalmia group. With a median follow-up of 46 months, the 3-year probability of event-free survival was 0.97 (95% CI, 0.94-0.99), and the probability of overall survival was 0.98 (95% CI, 0.94-1.00). Stage 0 patients had no events, stage I low-risk patients had 1 event (orbital relapse treated with second-line therapy), stage I high-risk patients had 2 events (1 central nervous system relapse and 1 death from sepsis), and the buphthalmia group had 1 event (orbital relapse, followed by central nervous relapse and death). Conclusions and Relevance: Adjuvant therapy may be effective for high-risk unilateral retinoblastoma but is toxic, and neoadjuvant chemotherapy for buphthalmus appears feasible.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Retinal Neoplasms/drug therapy , Retinoblastoma/drug therapy , Carboplatin/administration & dosage , Child , Child, Preschool , Cyclophosphamide/administration & dosage , Disease-Free Survival , Etoposide/administration & dosage , Eye Enucleation , Female , Humans , Hydrophthalmos/complications , Idarubicin/administration & dosage , Infant , Male , Mesna/administration & dosage , Neoplasm Metastasis , Neoplasm Staging , Prospective Studies , Retinal Neoplasms/mortality , Retinal Neoplasms/pathology , Retinoblastoma/mortality , Retinoblastoma/pathology , Survival Rate , Vincristine/administration & dosage
7.
J Heart Valve Dis ; 26(4): 472-480, 2017 07.
Article in English | MEDLINE | ID: mdl-29302948

ABSTRACT

BACKGROUND AND AIM OF THE STUDY: Xenograft conduits have been used successfully to repair congenital heart defects, but are prone to failure over time. Hence, in order to improve patient outcomes, better xenografts are being developed. When evaluating a conduit's performance and safety it must first be compared against a clinically available control in a large animal model. The study aim was to evaluate a clinically available xenograft conduit used in right ventricular outflow tract (RVOT) reconstruction in a sheep model. METHODS: RVOT reconstruction was performed in 13 adult and juvenile sheep, using the Medtronic Hancock® Bioprosthetic Valved Conduit (Hancock conduit). The method had previously been used on patients, and a newly modified variant termed 'RVOT Extraction' was employed to facilitate the surgical procedure. Animals were monitored over predetermined terms of 70 to 140 days. Serial transthoracic echocardiography, intracardiac pressure measurements and angiography were performed. On study completion the animals were euthanized and necropsies performed. RESULTS: Two animals died prior to their designated study term due to severe valvular stenosis and distal conduit narrowing, respectively. Thus, 11 animals survived the study term, with few or no complications. Generally, maximal and mean transvalvular pressure gradients across the implanted conduits were increased throughout the postoperative course. Among 11 full-term animals, seven conduits were patent with mild or no pseudointimal proliferation and with flexible leaflets maintaining the hemodynamic integrity of the valve. CONCLUSIONS: RVOT reconstruction using the Hancock conduit was shown to be successful in sheep, with durable and efficient performances. With its extensive clinical use in patients, and ability for long-term use in sheep (as described in the present study) it can be concluded that the Hancock conduit is an excellent control device for the evaluation of new xenografts in future preclinical studies.


Subject(s)
Bioprosthesis , Blood Vessel Prosthesis Implantation/instrumentation , Blood Vessel Prosthesis , Heart Valve Prosthesis Implantation/instrumentation , Heart Valve Prosthesis , Heart Ventricles/surgery , Pulmonary Artery/surgery , Pulmonary Valve/surgery , Animals , Blood Vessel Prosthesis Implantation/adverse effects , Echocardiography, Doppler, Color , Feasibility Studies , Heart Valve Prosthesis Implantation/adverse effects , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Heterografts , Materials Testing , Models, Animal , Polyethylene Terephthalates , Prosthesis Design , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/physiopathology , Pulmonary Circulation , Pulmonary Valve/diagnostic imaging , Pulmonary Valve/physiopathology , Sheep, Domestic , Time Factors , Ventricular Function, Right
8.
Xenotransplantation ; 22(4): 295-301, 2015.
Article in English | MEDLINE | ID: mdl-26031609

ABSTRACT

Endothelial cell activation and injury by the terminal pathway of complement is important in various pathobiological processes, including xenograft rejection. Protection against injury by human complement can be induced in porcine endothelial cells (ECs) with IL-4 and IL-13 through metabolic activation. However, despite this resistance, the complement-treated ECs were found to lose membrane permeability control assessed with the small molecule calcein. Therefore, to define the apparent discrepancy of permeability changes vis-à-vis the protection from killing, we now investigated whether IL-4 and IL-13 influence the release of the large cytoplasmic protein lactate dehydrogenase (LDH) in ECs incubated with complement or the pore-forming protein melittin. Primary cultures of ECs were pre-treated with IL-4 or IL-13 and then incubated with human serum as source of antibody and complement or melittin. Cell death was assessed using neutral red. Membrane permeability was quantitated measuring LDH release. We found that IL-4-/IL-13-induced protection of ECs from killing by complement or melittin despite loss of LDH in amounts similar to control ECs. However, the cytokine-treated ECs that were protected from killing rapidly regained effective control of membrane permeability. Moreover, the viability of the protected ECs was maintained for at least 2 days. We conclude that the protection induced by IL-4/IL-13 in ECs against lethal attack by complement or melittin is effective and durable despite severe initial impairment of membrane permeability. The metabolic changes responsible for protection allow the cells to repair the membrane injury caused by complement or melittin.


Subject(s)
Complement System Proteins/toxicity , Endothelial Cells/immunology , Graft Rejection/immunology , Graft Rejection/prevention & control , Interleukin-13/administration & dosage , Interleukin-4/administration & dosage , Melitten/toxicity , Animals , Cell Membrane Permeability/drug effects , Cell Membrane Permeability/immunology , Cytoplasm/metabolism , Cytotoxicity, Immunologic , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Humans , L-Lactate Dehydrogenase/metabolism , Swine , Transplantation, Heterologous/adverse effects , Transplantation, Heterologous/methods
9.
J Biol Chem ; 289(2): 838-47, 2014 Jan 10.
Article in English | MEDLINE | ID: mdl-24280217

ABSTRACT

Injury to endothelial cells (ECs) often results in cell retraction and gap formation. When caused by antigen aggregation or complement, this injury can be prevented by pretreatment of the ECs with IL-4, suggesting that IL-4 modifies the intercellular junction. Therefore, we investigated the effects of IL-4 on expression of intercellular junction proteins and whether such effects are required for IL-4-induced resistance of ECs against complement-mediated injury. We found that IL-4 induces upregulation of the junction protein claudin-5 in porcine ECs through activation of Jak/STAT6 and phosphorylation and translocation of FoxO1 from the nucleus to the cytoplasm. Increased claudin-5 expression resulted in increased transmembrane electrical resistance of the endothelial monolayer and participated in IL-4-induced protection of the ECs from complement injury. Down-regulation of FoxO1 using siRNA by itself caused up-regulation of claudin-5 expression and partial protection from cytotoxicity. This protection was enhanced by stimulation with IL-4. We previously reported that increased phospholipid synthesis and mitochondrial protection were required for IL-4-induced resistance of ECs against complement injury and now we demonstrate a contribution of claudin-5 expression in IL-4-induced protection.


Subject(s)
Claudin-5/metabolism , Endothelial Cells/drug effects , Forkhead Transcription Factors/metabolism , Interleukin-4/pharmacology , Up-Regulation/drug effects , Animals , Cell Nucleus/metabolism , Cell Survival/drug effects , Cells, Cultured , Complement System Proteins/toxicity , Cytoplasm/metabolism , Endothelial Cells/metabolism , Forkhead Transcription Factors/genetics , Humans , Immunoblotting , Janus Kinase 3/antagonists & inhibitors , Janus Kinase 3/metabolism , Microscopy, Confocal , Microscopy, Fluorescence , Phosphorylation/drug effects , Protein Transport/drug effects , Pyrimidines/pharmacology , Pyrroles/pharmacology , RNA Interference , STAT6 Transcription Factor/genetics , STAT6 Transcription Factor/metabolism , Swine
10.
Plant Biol (Stuttg) ; 15(5): 819-31, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23528138

ABSTRACT

Plant cell wall modification is a critical component in stress responses. Endo-1,4-ß-glucanases (EGs) take part in cell wall editing processes, e.g. elongation, ripening and abscission. Here we studied the infection response of Solanum lycopersicum and Arabidopsis thaliana with impaired EGs. Transgenic TomCel1 and TomCel2 tomato antisense plants challenged with Pseudomonas syringae showed higher susceptibility, callose priming and increased jasmonic acid pathway marker gene expression. These two EGs could be resistance factors and may act as negative regulators of callose deposition, probably by interfering with the defence-signalling network. A study of a set of Arabidopsis EG T-DNA insertion mutants challenged with P. syringae and Botrytis cinerea revealed that the lack of other EGs interferes with infection phenotype, callose deposition, expression of signalling pathway marker genes and hormonal balance. We conclude that a lack of EGs could alter plant response to pathogens by modifying the properties of the cell wall and/or interfering with signalling pathways, contributing to generate the appropriate signalling outcomes. Analysis of microarray data demonstrates that EGs are differentially expressed upon many different plant-pathogen challenges, hormone treatments and many abiotic stresses. We found some Arabidopsis EG mutants with increased tolerance to osmotic and salt stress. Our results show that impairing EGs can alter plant-pathogen interactions and may contribute to appropriate signalling outcomes in many different biotic and abiotic plant stress responses.


Subject(s)
Arabidopsis/metabolism , Botrytis , Cellulase/metabolism , Disease Resistance , Plant Diseases/microbiology , Pseudomonas syringae , Solanum lycopersicum/metabolism , Arabidopsis/genetics , Cell Wall/enzymology , Cell Wall/metabolism , Cellulase/genetics , Cyclopentanes/metabolism , Disease Resistance/genetics , Gene Expression , Gene Expression Regulation, Plant , Genes, Plant , Glucans/metabolism , Host-Pathogen Interactions/genetics , Solanum lycopersicum/genetics , Oxylipins/metabolism , Plant Diseases/genetics , Plant Growth Regulators/genetics , Plant Growth Regulators/metabolism , Plant Proteins/genetics , Plant Proteins/metabolism , Signal Transduction
11.
J Investig Allergol Clin Immunol ; 22(5): 313-30; quiz follow 330, 2012.
Article in English | MEDLINE | ID: mdl-23101306

ABSTRACT

Correct management of latex allergy is essential to ensure adequate care of patients who are allergic to latex, which is ubiquitous in the health care setting. In this Position Paper, the Latex Committee of the Spanish Society of Allergology and Clinical Immunology provides guidelines for the management of latex allergy.


Subject(s)
Latex Hypersensitivity/diagnosis , Allergens/immunology , Environmental Exposure , Humans , Latex/immunology , Latex Hypersensitivity/prevention & control , Latex Hypersensitivity/therapy
12.
Mycorrhiza ; 22(6): 485-91, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22752460

ABSTRACT

The kinetics and energetics of (15)NH (4) (+) uptake by the extraradical mycelium of the arbuscular mycorrhizal fungus Rhizophagus irregularis were investigated. (15)NH (4) (+) uptake increased with increasing substrate concentration over the concentration range of 0.002 to 25 mM. Eadie-Hofstee plots showed that ammonium (NH (4) (+) ) uptake over this range was biphasic. At concentrations below 100 µM, NH (4) (+) uptake fits a Michaelis-Menten curve, typical of the activity of a saturable high-affinity transport system (HATS). At concentrations above 1 mM, NH (4) (+) influx showed a linear response typical of a nonsaturable low-affinity transport system (LATS). Both transport systems were dependent on external pH. The HATS and, to a lesser extent, the LATS were inhibited by the ionophore carbonylcyanide m-chlorophenylhydrazone (CCCP) and the ATP-synthesis inhibitor 2,4-dinitrophenol. These data indicate that the two NH (4) (+) transport systems of R. irregularis are dependent on metabolic energy and on the electrochemical H(+) gradient. The HATS- and the LATS-mediated (15)NH (4) (+) influxes were also regulated by acetate. This first report of the existence of active high- and low-affinity NH4(+) transport systems in the extraradical mycelium of an arbuscular mycorrhizal fungus and provides novel information on the mechanisms underlying mycosymbiont uptake of nitrogen from the soil environment.


Subject(s)
Acetates/pharmacology , Ammonium Compounds/metabolism , Daucus carota/microbiology , Glomeromycota/metabolism , Mycorrhizae/metabolism , 2,4-Dinitrophenol/pharmacology , Biological Transport/drug effects , Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology , Daucus carota/metabolism , Dose-Response Relationship, Drug , Glomeromycota/drug effects , Hydrogen-Ion Concentration , Kinetics , Mycelium/drug effects , Mycelium/metabolism , Mycorrhizae/drug effects , Nitrogen/metabolism , Nitrogen Isotopes , Plant Roots/metabolism , Plant Roots/microbiology
13.
Xenotransplantation ; 19(3): 137-43, 2012.
Article in English | MEDLINE | ID: mdl-22702465

ABSTRACT

I am very grateful to the Council and members of the International Xenotransplantation Association for this Honorary Membership. In accepting this prestigious award, I pay tribute to my mentors Antonio Oriol i Anguera, Carlos Martinez, Robert A. Good, and Hans Müller-Eberhard for their guidance and friendship as I was beginning my travels in biomedical research. I also thank the many gifted collaborators, students, and technical personnel, as well as the agencies and taxpayers, who funded our research and made our scientific contributions possible. Here I briefly mention some of these contributions, including early work on the immunobiology of the thymus, my short incursion in the immunology of Chagas disease, and what have been the dominant themes of my career: the mechanisms of complement injury, the role of complement in pathophysiology, and induction of cytoprotection in the vascular endothelium. I emphasize our contributions on the role of complement as related to understanding and overcoming xenograft injury, a work that has been personally very rewarding. Now it is exciting to see that the field of xenotransplantation research is moving forward vigorously, a time of great optimism suggesting that many potential clinical applications of xenotransplantation will come to fruition in the near future.


Subject(s)
Awards and Prizes , Chagas Disease/history , Graft Rejection/history , Translational Research, Biomedical/history , Transplantation, Heterologous/history , Animals , History, 20th Century , History, 21st Century , Humans
15.
Xenotransplantation ; 18(6): 343-54, 2011.
Article in English | MEDLINE | ID: mdl-22168141

ABSTRACT

BACKGROUND: Apoptosis is crucial for tissue development and homeostasis, and insufficient apoptosis is pivotal in cancer pathogenesis. Apoptosis may also be important in tissue injury and in this case, it is of interest to induce protection against apoptosis. In organ transplantation, apoptosis has been implicated in acute vascular rejection (AVR); in xenotransplantation, the inducers of apoptosis of relevance in AVR, such as tumor necrosis factor-α (TNF-α), also cause endothelial cell (EC) activation. We have previously shown that interleukin (IL)-4 and IL-13 induced protection in porcine ECs against activation and apoptosis triggered by TNF-α. Now we define signaling processes activated by IL-4 in porcine ECs and mechanisms required for IL-4-induced protection against apoptosis. METHODS: Porcine aortic ECs were used as primary cultures or as virus-induced immortalized cells derived from galactosyl transferase-deficient (Gal(-/-) ) or wild-type pigs. ECs were stimulated with porcine IL-4, either extrinsically or transduced with recombinant adenovirus (adeno) IL-4, and analyzed using immunoblotting. Apoptosis was induced with TNF-α plus cycloheximide and assessed using neutral red uptake or flow cytometry. The role of various signaling proteins in IL-4-induced protection was established using pharmacologic inhibitors and siRNA downregulation of protein expression. RESULTS: IL-4 induced similar degrees of phosphorylation of STAT6 in all 3 types of ECs, and STAT6 was phosphorylated through Jak3. IL-4 induced phosphorylation of Bad through Jak3. Stimulation of ECs with IL-4 caused protection of ECs against apoptosis with an absolute requirement of Jak3/STAT6 activation and major participation of mammalian target of rapamycin complex 2 (mTORC2), Akt, and extracellular signal-regulated kinase 1/2. IL-4 caused no increase in EC levels of protective proteins hemoxygenase-1, inhibitor of apoptosis protein, heat shock protein 70, Bcl-2, and Bcl-xL. ECs transduced with adenoIL-4 exhibited strong and durable protection from apoptosis. Gal(-/-) ECs were as susceptible to induction of protection with IL-4 as wild-type ECs. CONCLUSIONS: IL-4 induces activation of Jak3/STAT6 and phosphorylation of Bad in porcine ECs, ultimately resulting in effective protection of the ECs from apoptosis. Delineation of downstream signals activated by IL-4 that are required for induction of protection suggests possible sites of intervention to design effective therapeutic agents. This is of interest because substances such as IL-4 have pleiotropic effects and cannot be used directly due to potential deleterious effects. Inducing resistance to apoptosis in porcine vascular endothelium may be important to facilitate xenograft survival and accommodation.


Subject(s)
Apoptosis/drug effects , Endothelial Cells/drug effects , Endothelial Cells/physiology , Interleukin-4/pharmacology , Animals , Aorta/cytology , Cells, Cultured , Endothelial Cells/cytology , Enzyme Activation/drug effects , Humans , Janus Kinase 3/metabolism , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Proto-Oncogene Proteins c-akt/metabolism , STAT6 Transcription Factor/metabolism , Signal Transduction/drug effects , Swine , TOR Serine-Threonine Kinases/metabolism , bcl-Associated Death Protein/metabolism
16.
Cytopathology ; 21(2): 86-92, 2010 Apr.
Article in English | MEDLINE | ID: mdl-21054822

ABSTRACT

A European Federation of Cytology Societies (EFCS) working party of 28 members from 14 European countries met at the European Congress of Cytology in Lisbon in September 2009, with two observers from the USA, to discuss the need for standardising thyroid FNA nomenclature in the light of the National Institute of Cancer (NCI) recommendations resulting from the State of the Science conference in Bethesda in 2007. The data were obtained through two questionnaires sent by email and a transcript of the live discussion at the congress, which is presented in full. The surveys and discussion showed that there were currently no national terminologies for reporting thyroid FNA in the different European countries except in Italy and the UK. Personal, 'local', surgical pathology and descriptive terminologies were in use. All but one of the working party members agreed that thyroid FNA reporting should be standardised. Whilst almost a third would adopt the NCI Bethesda terminology, which offers the advantages of a 'risk of cancer' correlation and is linked to clinical recommendations, more than half favoured a translation of local terminology as the first step towards a unified nomenclature, as has been done recently in the UK. There was some disagreement about the use of: a) the six-tiered as opposed to four or five-tiered systems, b) the use of an indeterminate category and c) the 'follicular neoplasm' category, which was felt by some participants not to be different from the 'suspicious of malignancy' category. The conclusions will be passed to the different national societies of cytology for discussion, who will be asked to map their local terminologies to the Bethesda classification, observe its acceptance by clinicians and audit its correlation with outcome.


Subject(s)
Biopsy, Fine-Needle , Thyroid Diseases/pathology , Thyroid Gland/pathology , Biopsy, Fine-Needle/methods , Biopsy, Fine-Needle/standards , Europe , Humans , Practice Guidelines as Topic , Terminology as Topic
17.
Eur J Immunol ; 40(3): 803-12, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20017192

ABSTRACT

We have shown previously that cytokines IL-4 and IL-13 induce protection in porcine vascular endothelial cells (EC) against killing by the membrane attack complex (MAC) of human complement. This protection is intrinsic, not due to changes in complement regulatory proteins, and requires activation of Akt and sterol receptor element binding protein-1 (SREBP-1), which regulates fatty acid and phospholipid synthesis. Here we report that, compared to EC incubated in medium, IL-4-treated EC had a profound reduction in complement-mediated ATP loss and in killing assessed by vital dye uptake, but only a slight reduction in permeability disruption measured by calcein release. While controls exposed to complement lost mitochondrial membrane potential and subsequently died, protected EC maintained mitochondrial morphology and membrane potential, and remained alive. SREBP-1 and fatty acid synthase activation were required for protection and fatty acid and phospholipid synthesis, including cardiolipin, were increased after IL-4 stimulation, without increase in cholesterol content or cell proliferation. IL-4 also induced protection of EC from killing by the channel forming protein melittin, similar to protection observed for the MAC. We conclude that IL-4 induced activation of Akt/SREBP-1/lipid biosynthesis in EC, resulting in protection against MAC and melittin, in association with mitochondrial protection.


Subject(s)
Complement System Proteins/drug effects , Endothelial Cells/drug effects , Interleukin-4/pharmacology , Lipids/biosynthesis , Melitten/adverse effects , Signal Transduction/drug effects , Animals , Blotting, Western , Cell Membrane Permeability , Cell Separation , Complement Membrane Attack Complex/drug effects , Endothelial Cells/metabolism , Endothelial Cells/ultrastructure , Flow Cytometry , Interleukin-4/metabolism , Membrane Potential, Mitochondrial/drug effects , Microscopy, Electron, Transmission , Mitochondria/pathology , Proto-Oncogene Proteins c-akt/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Sterol Regulatory Element Binding Protein 1/drug effects , Sterol Regulatory Element Binding Protein 1/metabolism , Swine
18.
Arch. pediatr. Urug ; 79(4): 303-307, 2008. ilus
Article in Spanish | LILACS | ID: lil-567090

ABSTRACT

Los agujeros parietales ensanchados, también llamados formina parietallia permagna o agujeros parietales gigantes, son un defecto congénito, identificados en el examen físico y confirmados imagenológicamente. Se presenta el caso de un lactante de 2 meses de edad, sin antecedentes personales a destacar, que desde el nacimiento presenta una tumefacción en el cuero cabelludo, a nivel de la fontanela lambdoidea. Se solicitan estudios imagenológicos para completar la valoración del paciente. La patología presentada motiva una serie de diagnósticos diferenciales, que deben ser recordados, los cuales pueden ser descartados fácilmente mediante la tomografía computada con reconstrucción 3D.


Enlarged parietal foramen, also called foramina parietallia permagna or giant parietal foramen, is a congenital defect identified in the physical examination and confirmed with radiological studies.The case of a two month old infant with no relevant past medical history is presented. He had a small scalp tumour, which was evident at the lamboid fontanel since birth. Imaging studies were requested to complete the evaluation of this patient. The above mentioned disease accounts for several differential diagnosis which can be early ruled out through 3D CT scan.


Subject(s)
Humans , Infant , Parietal Bone/abnormalities
19.
Xenotransplantation ; 14(6): 572-9, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17991145

ABSTRACT

BACKGROUND: To induce accommodation in the hamster-to-rat cardiac transplantation model, in addition to cyclosporin A (CSA) to inhibit T-cell-mediated graft rejection, cobra venom factor (CVF) is often used to prevent complement-mediated graft rejection. Although it is generally assumed that CVF makes accommodation possible because it inactivates the complement membrane attack complex (MAC), it is not known which complement components must be inactivated and whether complement activation products generated by CVF are also involved in the induction of accommodation. Therefore, to investigate mechanisms by which CVF contributes to accommodation, we studied induction of accommodation of hamster hearts grafted into rats with complement deficiencies of C6; these rats cannot assemble the MAC but, in contrast to CVF, retain in their native state all complement proteins that precede the MAC. METHODS: Golden Syrian hamster hearts were transplanted heterotopically into the abdomen of normocomplementemic and C6-deficient (C6D) PVG rats. Graft rejection was determined by cessation of palpable cardiac contractions. CSA, 10 mg/kg, was administered daily to all rats. Graft survival was compared in rats given CVF (60 U/kg 1-day pre-transplant and 20 U/kg/day for the next 9 days), C6D rats given no CVF, normocomplementemic rats given anti-C6 IgG or non-immune IgG but no CVF, and C6D rats reconstituted with normocomplementemic rat serum. Total complement and C6 serum levels were measured using hemolytic assays in rat peripheral blood. RESULTS: We found that hamster hearts transplanted into C6D rats receiving CSA but no CVF survived long-term, with histology typical of an accommodated heart. The accommodated hamster heart did not reconstitute C6 levels of the C6D recipient rats. Moreover, in normocomplementemic rats given anti-C6 antibodies (abs) to induce partial C6 deficiency, accommodation also developed without administration of CVF. Accommodation of the hamster heart failed to develop in C6D rats whose complement was reconstituted by administration of normocomplementemic rat serum given before and following transplantation. CONCLUSIONS: These studies demonstrate that, in this model, inhibition of MAC-mediated graft rejection is sufficient to allow the development of accommodation. Inactivation of C3 or other complement proteins of the alternate pathway, or the presence of complement-derived biologically active fragments, is not needed for development of accommodation.


Subject(s)
Complement Membrane Attack Complex/antagonists & inhibitors , Graft Survival , Heart Transplantation/physiology , Transplantation, Heterologous/physiology , Animals , Cricetinae , Cyclosporine/therapeutic use , Elapid Venoms/therapeutic use , Heart Transplantation/immunology , Heart Transplantation/pathology , Male , Mesocricetus , Rats , Rats, Inbred Strains , Rats, Sprague-Dawley , Transplantation, Heterologous/immunology , Transplantation, Heterologous/pathology
20.
J Immunol ; 177(10): 7355-63, 2006 Nov 15.
Article in English | MEDLINE | ID: mdl-17082655

ABSTRACT

Vascular endothelial cells (ECs) can be injured in a variety of pathologic processes that involve activated complement. We reported previously that porcine ECs incubated with exogenous IL-4 or IL-13 are protected from cytotoxicity by human complement and also from apoptosis by TNF-alpha. The resistance to complement consists of an intrinsic mechanism that is lost a few days after cytokine removal. In our current study, we investigated whether transfer of the IL-4 gene into porcine ECs in vitro and into porcine vascular tissues in vivo would induce efficient and durable protection from human complement. We found that ECs transduced with adenoIL-4 or adenoIL-13 exhibited continuous production of the cytokine and prolonged protection from complement-mediated killing. IL-4 also protected ECs from activation: ECs incubated with IL-4 did not develop cell retraction and intercellular gaps upon stimulation with sublytic complement. The endothelium and subendothelium of pig iliac arteries that were transduced with the IL-4 gene were effectively protected from complement-dependent immediate injury after perfusion with human blood. However, after similar perfusion, the endothelium was immediately lost from arteries that were transduced with a control adenovirus. The protection was not due to up-regulation of the complement regulators decay accelerating factor, membrane cofactor protein, and CD59, or to reduced complement activation, but required the participation of Akt. Although our studies model protection in pig-to-primate xenotransplantation, our findings of IL-4 induction of Akt-mediated protection may be more broadly applicable to EC injury as manifested in ischemia-reperfusion, allotransplantation, and various vascular diseases.


Subject(s)
Complement System Proteins/toxicity , Endothelium, Vascular/immunology , Endothelium, Vascular/metabolism , Iliac Artery/immunology , Iliac Artery/metabolism , Interleukin-4/genetics , Proto-Oncogene Proteins c-akt/metabolism , Transduction, Genetic , Adenoviridae/genetics , Animals , Blood/immunology , Cells, Cultured , Complement System Proteins/metabolism , Cytotoxicity, Immunologic/genetics , Endothelium, Vascular/cytology , Extracellular Fluid/immunology , Extracellular Fluid/metabolism , Gene Transfer Techniques , Humans , Iliac Artery/cytology , Immunity, Innate/genetics , Interleukin-13/biosynthesis , Interleukin-13/genetics , Interleukin-4/biosynthesis , Interleukin-4/physiology , Perfusion , Proto-Oncogene Proteins c-akt/physiology , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...